VNRX (VNRX) Stock Price & Analysis
VNRX (VNRX) fell 3.03% to USD 0.34 as of September 8, 2026 at 15:30 UTC, according to Nexqual real-time market data.
VNRX last closed at USD 0.34; the session ranged USD 0.33–0.34 on volume of 592,331 shares. Market capitalization is —, with a 52-week range of USD 0.33–14.8 (ASE). Source: Nexqual, September 8, 2026 at 15:30 UTC.
Key Statistics (as of September 8, 2026 at 15:30 UTC)
| Price | USD 0.34 |
|---|---|
| Change | ▼ 3.03% (down) |
| Previous Close | USD 0.34 |
| Open | USD 0.34 |
| Day Range | USD 0.33 – 0.34 |
| 52-Week Range | USD 0.33 – 14.8 |
| Volume | 592,331 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (VNRX)
Nexqual's technical model rates VNRX "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 15:30 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 27.18 (oversold) |
| vs SMA50 | Below (USD 0.83) |
| MACD | -0.14 (negative) |
From VNRX's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MLSS | Milestone Scientific, Inc. | USD 0.46 | ▼ 2.15% |
| EVGN | Evogene Ltd. | USD 0.52 | ▼ 5.45% |
| ECOR | electroCore, Inc. | USD 8.97 | ▼ 2.61% |
| IMDX | Insight Molecular Diagnostics I | USD 4.06 | ▼ 1.46% |
| NDRA | ENDRA Life Sciences Inc. | USD 5.93 | ▲ 4.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 15:30 UTC. This page is informational and not investment advice.